Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(+/-)-2-methoxymandelic acid is a chemical compound with the molecular formula C9H10O4. It is a racemic mixture of both the dextrorotatory and levorotatory forms of 2-methoxymandelic acid, a derivative of mandelic acid. (+/-)-2-methoxymandelic acid has been studied for its potential use in pharmaceuticals, particularly as an intermediate in the synthesis of various drugs. It is also used in the manufacture of chiral catalysts and as a building block in organic synthesis. (+/-)-2-methoxymandelic acid may have applications in the development of new drugs and in chemical research.

89709-23-9

Post Buying Request

89709-23-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

89709-23-9 Usage

Uses

Used in Pharmaceutical Industry:
(+/-)-2-methoxymandelic acid is used as an intermediate in the synthesis of various drugs for its potential applications in pharmaceuticals.
Used in Chemical Research:
(+/-)-2-methoxymandelic acid is used as a building block in organic synthesis for its potential applications in the development of new drugs and in chemical research.
Used in Chiral Catalysts Manufacturing:
(+/-)-2-methoxymandelic acid is used in the manufacture of chiral catalysts for its potential applications in asymmetric synthesis and other chemical processes.

Check Digit Verification of cas no

The CAS Registry Mumber 89709-23-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,7,0 and 9 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 89709-23:
(7*8)+(6*9)+(5*7)+(4*0)+(3*9)+(2*2)+(1*3)=179
179 % 10 = 9
So 89709-23-9 is a valid CAS Registry Number.

89709-23-9Downstream Products

89709-23-9Relevant articles and documents

Enzyme Optimization and Process Development for a Scalable Synthesis of (R)-2-Methoxymandelic Acid

Brown, Gareth,Chan, Johann,Dourado, Daniel F. A. R.,Geier, Michael J.,Gray, Darren,Humphreys, Luke D.,Kannan, Balamurali,Mix, Stefan,Pukin, Aliaksei,Scott, Mark E.,Wang, Xiaotian

supporting information, (2021/09/02)

The rational protein engineering of wild type BCJ2315 nitrilase and its use in the development of a one-pot, enantioselective, dynamic kinetic resolution for (R)-2-methoxymandelic acid is reported. Through a combination of molecular docking and B-factor a

PROCESSES FOR PREPARING ACC INHIBITORS AND SOLID FORMS THEREOF

-

Paragraph 0418, (2018/09/20)

The present disclosure provides solid forms, including a salt or co-crystal, of Compound I which exhibits Acetyl-CoA carboxylase ("ACC") inhibitory activity and may be useful in treating ACC mediated diseases. Also provided herein are processes or steps f

The Synthesis of Chiral α-Aryl α-Hydroxy Carboxylic Acids via RuPHOX-Ru Catalyzed Asymmetric Hydrogenation

Guo, Huan,Li, Jing,Liu, Delong,Zhang, Wanbin

, p. 3665 - 3673 (2017/09/11)

A ruthenocenyl phosphino-oxazoline-ruthenium complex (RuPHOX?Ru) catalyzed asymmetric hydrogenation of α-aryl keto acids has been successfully developed, affording the corresponding chiral α-aryl α-hydroxy carboxylic acids in high yields and with up to 97% ee. The reaction could be performed on a gram scale with a relatively low catalyst loading (up to 5000 S/C) and the resulting products can be transformed to several chiral building blocks, biologically active compounds and chiral drugs. (Figure presented.).

Asymmetric hydrogenation reaction of alpha-ketoacids compound

-

Paragraph 0031; 0032; 0033; 0037; 0043, (2016/10/10)

The invention relates to the technical field of organic chemistry, especially to an asymmetric hydrogenation reaction of an alpha-ketoacids compound. The asymmetric hydrogenation reaction comprises a scheme shown in the description. In the scheme, R1 is phenyl, substituted phenyl, naphthyl, substituted naphthyl, C1-C6 alkyl, or aralkyl; a substituent group is C1-C6 alkyl, C1-C6 alkoxy, or halogen; and the number of the substituent group is 1-3. In the scheme, M is a chiral spiro-pyridylamino phosphine ligand iridium complex having a structure shown in the description. In the structure, R is hydrogen, 3-methyl, 4-tBu, or 6-methyl.

Relationships between the racemic structures of substituted mandelic acids containing 8- and 10-membered hydrogen bonded dimer rings

Coles,Ellis,Leung,Sarson,Threlfall,Tizzard

, p. 10816 - 10823 (2015/02/19)

The structures of 27 monosubstituted mandelic acids, including several of their polymorphs, plus unsubstituted mandelic acid itself (two polymorphs) are investigated for structural similarity. The results, presented pictorially as a structural relationship plot, show that rather more structures are built up from the carboxyl-chain hydroxyl hydrogen bonded dimer than from the conventional carboxylic acid dimer. The results show how all the structures are related and, based on the two types of dimer, the degree of similarity that they possess. Some structures with Z′ > 1 contain both sorts of dimers and there are many examples of isostructural sets within the structures so far determined. We also present an example where analysing similarity in related families of structures highlights a structure that should be present and which has indeed then proceeded to be synthesised and determined.

Direct asymmetric hydrogenation of α-keto acids by using the highly efficient chiral spiro iridium catalysts

Yan, Pu-Cha,Xie, Jian-Hua,Zhang, Xiang-Dong,Chen, Kang,Li, Yuan-Qiang,Zhou, Qi-Lin,Che, Da-Qing

, p. 15987 - 15990 (2015/02/19)

A new efficient and highly enantioselective direct asymmetric hydrogenation of α-keto acids employing the Ir/SpiroPAP catalyst under mild reaction conditions has been developed. This method might be feasible for the preparation of a series of chiral α-hydroxy acids on a large scale.

The preparation of various new heterocyclic compounds via cyclization of substituted derivatives of phenacyl esters of hydrazonoacetic acid

Melnicky, Radek,Grepl, Martin,Lycka, Antonin,Bertolasi, Valerio,Kvapil, Lubomir,Dvorakova, Barbora,Hradil, Pavel

, p. 2447 - 2457 (2013/09/23)

A procedure for the preparation of derivatives of phenacyl hydrazonopropanoates and their application in the synthesis of various heterocycles has been developed. Not only is the preparation of indole derivatives described, but also a new method for the preparation of previously unknown pyridazine derivatives.

A rapid and green approach to chiral α-hydroxy esters: asymmetric transfer hydrogenation (ATH) of α-keto esters in water by use of surfactants

Yin, Lu,Jia, Xian,Li, Xingshu,Chan, Albert S.C.

experimental part, p. 2033 - 2037 (2010/01/16)

A series of α-hydroxy esters were rapidly prepared (1.5 h) from α-keto esters via asymmetric transfer hydrogenation (ATH) in water by the use of surfactants for the first time. This green method, catalyzed by a water-soluble and recyclable Ru(II) complex, gave moderate to high enantioselectivities (up to 99.7% ee) with DTAB as an additive and HCOONa as the hydrogen source.

CeCl3·7H2O: An effective additive in ru-catalyzed enantioselective hydrogenation of aromatic α-ketoesters

Meng, Qinghua,Sun, Yanhui,Ratovelomanana-Vidal, Virginie,Genet, Jean Pierre,Zhang, Zhaoguo

, p. 3842 - 3847 (2008/09/21)

(Chemical Equation Presented) In the presence of catalytic amounts of CeCl3·7H2O, [RuCl(benzene)(S)-SunPhos]Cl is a highly effective catalyst for the asymmetric hydrogenation of aromatic α-ketoesters. A variety of ethyl α-hydroxy-α-arylacetates have been prepared in up to 98.3% ee with a TON up to 10 000. Challenging aromatic α-ketoesters with ortho substituents are also hydrogenated with high enantioselectivities. The addition of CeCl3·7H2O not only improves the enantioselectivity but also enhances the stability of the catalyst. The ratio of CeCl3·7H2O to [RuCl(benzene)(S)-SunPhos]Cl plays an important role in the hydrogenation reaction with a large substrate/catalyst ratio.

Chemically modified mutant serine hydrolases show improved catalytic activity and chiral selectivity

-

, (2008/06/13)

This invention provides novel chemically modified mutant serine hydrolases that catalyze a transamidation and/or a transpeptidation and/or a transesterification reaction. The modified serine hydrolases have one or more amino acid residues in a subsite replaced with a cysteine, wherein the cysteine is modified by replacing the thiol hydrogen in the cysteine with a substituent group providing a thiol side chain comprising a moiety selected from the group consisting of a polar aromatic substituent, an alkyl amino group with a positive charge, and a glycoside. In particularly preferred embodiments, the substitutents include an oxazolidinone, a C1 to C15 alkyl amino group with a positive charge, or a glycoside.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 89709-23-9